Pseudoprogression and hyperprogression secondary to immunotherapy in lung cancer

BACKGROUND: The treatment of non-small cell lung cancer (NSCLC) has undergone changes that have improved the prognosis of patients. With the advent of immunotherapy, it has been possible to prolong significantly the overall and progression-free survival as well as quality of life. Nevertheless, its...

Descripción completa

Detalles Bibliográficos

Autores principales:	R. Riera-Sala, A. Ibarra-Morales, J. Guzmán-Casta, R. Medrano-Guzmán, A. Dip-Borunda, A. Martin-Aguilar, R. Grajales-Álvarez, R. Correa-Cano, K. Elvira-Fabián, C. Sánchez-Ríos, A. Orzuna-Vázquez, J. Rovelo-Lima, L. Martínez-Barrera, J. Rodríguez-Cid, J. Alatorre-Alexander
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Verduci Editore 2023-09-01
Colección:	World Cancer Research Journal
Materias:	pseudoprogression hyperprogression immunotherapy lung cancer
Acceso en línea:	https://www.wcrj.net/wp-content/uploads/sites/5/2023/09/e2660.pdf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!